Quantitative, spectrally-resolved intraoperative fluorescence imaging

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Valdés, Pablo A ^a,b,c   Leblond, Frederic ^a   Jacobs, Valerie L ^b   Wilson, Brian C ^d   Paulsen, Keith D ^a,b,c   Roberts, David W ^b,c  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORESCENT DYE; PROTOPORPHYRIN;

ANIMAL; ARTICLE; BRAIN TUMOR; FLUORESCENCE; FLUORESCENCE IMAGING; GLIOMA; HUMAN; IMAGE QUALITY; INSTRUMENTATION; INTRAOPERATIVE PERIOD; METHODOLOGY; RAT;

ANIMALS; BRAIN NEOPLASMS; FLUORESCENCE; FLUORESCENT DYES; GLIOMA; HUMANS; INTRAOPERATIVE PERIOD; OPTICAL IMAGING; PHANTOMS, IMAGING; PROTOPORPHYRINS; RATS;

EID: 84869178659     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00798     Document Type: Article

References (30)

1. Qiu, L. et al. Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus. Nat Med 16, 603-606, 601p following 606 (2010).
2. van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. NatMed 17, 1315-1319 (2011).
3. Whitney, M. A. et al. Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat Biotechnol 29, 352-356 (2011).
4. Yoo, H. et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med 17, 1680-1684 (2011).
5. Sanai, N. & Berger, M. S. Glioma extent of resection and its impact on patient outcome. Neurosurgery 62, 753-764; discussion 264-756 (2008).
6. Pouratian, N., Asthagiri, A., Jagannathan, J., Shaffrey, M. E. & Schiff, D. Surgery Insight: the role of surgery in the management of low-grade gliomas. Nat Clin Pract Neurol 3, 628-639 (2007). (Pubitemid 350048229)
7. Smitt, M. C. et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76, 259-267 (1995).
8. Eastham, J. A. et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. The Journal of urology 170, 2292-2295 (2003). (Pubitemid 37413978)
9. Fisher, B. et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347, 1233-1241 (2002). (Pubitemid 35176242)
10. Karakiewicz, P. I. et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 66, 1245-1250 (2005). (Pubitemid 41797299)
11. Goharderakhshan, R. Z. et al. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. Urology 59, 709-714 (2002). (Pubitemid 34461982)
12. Jansen, M., Yip, S. & Louis, D. N. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol 9, 717-726 (2010).
13. Louis, D. N. et al. The 2007WHOclassification of tumours of the central nervous system. Acta Neuropathol 114, 97-109 (2007). (Pubitemid 47103521)
14. Kriss, T. C. & Kriss, V. M. History of the operating microscope: from magnifying glass to microneurosurgery. Neurosurgery 42, 899-907; discussion 907-898 (1998).
15. Willems, P. W., van der Sprenkel, J. W., Tulleken, C. A., Viergever, M. A. & Taphoorn, M. J. Neuronavigation and surgery of intracerebral tumours. J Neurol 253, 1123-1136 (2006). (Pubitemid 44511467)
16. Galloway, R. L., Jr. The process and development of image-guided procedures. Annu Rev Biomed Eng 3, 83-108 (2001).
17. Wen, P. Y. & Kesari, S. Malignant gliomas in adults. N Engl J Med 359, 492-507 (2008).
18. Stummer, W. et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7, 392-401 (2006).
19. Pogue, B. W. et al. Review of Neurosurgical Fluorescence ImagingMethodologies. IEEE J Sel Top Quantum Electron 16, 493-505 (2010).
20. Ntziachristos, V., Yoo, J. S. & van Dam, G. M. Current concepts and future perspectives on surgical optical imaging in cancer. J Biomed Opt 15, 066024 (2010).
21. Bradley, R. S. & Thorniley, M. S. A review of attenuation correction techniques for tissue fluorescence. J R Soc Interface 3, 1-13 (2006). (Pubitemid 46682200)
22. Valdes, P. A. et al. d-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. Neuro Oncol 13, 846-856 (2011).
23. Valdes, P. A. et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 115, 11-17 (2011).
24. Richards-Kortum, R. & Sevick-Muraca, E. Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem 47, 555-606 (1996). (Pubitemid 126416975)
25. Weissleder, R. & Pittet, M. J. Imaging in the era of molecular oncology. Nature 452, 580-589 (2008). (Pubitemid 351483372)
26. Valdes, P. A. et al.Aspectrally constrained dual-band normalization technique for protoporphyrin IX quantification in fluorescence-guided surgery. Opt Lett 37, 1817-1819 (2012).
27. Kim, A., Khurana, M., Moriyama, Y. & Wilson, B. C. Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiberoptic spectroscopy measurements. J Biomed Opt 15, 067006 (2010).
28. Tichauer, K. M. et al. InVivo Quantification of Tumor Receptor Binding Potential with Dual-Reporter Molecular Imaging. Mol Imaging Biol (2011).
29. Ntziachristos, V. Going deeper than microscopy: the optical imaging frontier in biology. Nature Methods 7, 603-614 (2010).
30. Jacobs, V. L., Valdes, P. A., Hickey, W. F. & De Leo, J. A. Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumor model. ASN Neuro 3, e00063 (2011).